Pharmacological treatment optimisation for stable COPD: an endless story?

Maeva Zysman, François Chabot, Bruno Housset, Capucine Morelot Panzini, Philippe Devillier, Nicolas Roche

Source: Eur Respir J, 50 (4) 1701250; 10.1183/13993003.01250-2017
Journal Issue: October
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Maeva Zysman, François Chabot, Bruno Housset, Capucine Morelot Panzini, Philippe Devillier, Nicolas Roche. Pharmacological treatment optimisation for stable COPD: an endless story?. Eur Respir J, 50 (4) 1701250; 10.1183/13993003.01250-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017



Bronchodilator testing: an endless story
Source: Eur Respir J 2010; 35: 952-954
Year: 2010


Pharmacological options for the treatment of COPD: present and future
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007

Tuberculosis elimination, patients' lives and rational use of new drugs: revisited
Source: Eur Respir J 2016; 47: 664-667
Year: 2016


Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think?
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018


Rational monitoring of COPD: where do current clinical guidelines stand?
Source: Eur Respir J 2007; 29: 1078-1081
Year: 2007


Optimising bronchodilator therapy in COPD: Who, why and when?
Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care
Year: 2019

Evaluating disease-modifying treatment in CF: are we ready to take the challenge?
Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases"
Year: 2014



COPD: time to improve its taxonomy?
Source: ERJ Open Res, 4 (1) 00132-2017; 10.1183/23120541.00132-2017
Year: 2018



Pharmacological treatment of COPD: the devil is always in the detail
Source: Eur Respir J, 51 (4) 1800263; 10.1183/13993003.00263-2018
Year: 2018



Improving symptomology in COPD: which therapy would you choose, a brochodilator or pulmonary rehabilitation?
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019


Breathing issues in COPD, what a physio can offer?
Source: Annual Congress 2010 - Breathing issues in COPD, what a physiotherapist can offer
Year: 2010

Chronic cough: Are we integrating non-pharmacological therapies into treatment plans?
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017


Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015


The concept of control in COPD: a new proposal for optimising therapy
Source: Eur Respir J 2014; 44: 1072-1075
Year: 2014